Tadalafil Api Coa
In preclinical laboratory investigation, obtaining a lot-specific Certificate of Analysis (COA) for active pharmaceutical ingredients (APIs) is essential to ensure experimental repeatability and rigorous quantitative controls. This guide outlines the key analytical metrics documented on a valid Tadalafil API COA, detailing high-performance liquid chromatography, mass spectrometry identity confirmation, and bioburden parameters required for compliant in vitro research.
Quick answer
In preclinical laboratory investigation, obtaining a lot-specific Certificate of Analysis (COA) for active pharmaceutical ingredients (APIs) is essential to ensure experimental repeatability and rigorous quantitative controls. This guide outlines the key analytical metrics documented on a valid Tadalafil API COA, detailing high-performance liquid chromatography, mass spectrometry identity confirmation, and bioburden parameters required for compliant in vitro research.
Key takeaways
- A Tadalafil API [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) is a lot-specific analytical document verifying the chemical identity, purity grade, and physical specifications of research-grade Tadalafil active pharmaceutical ingredient.
- Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor widely utilized in cardiovascular, vascular smooth muscle, and cellular signaling research.
- A compliant [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) for Tadalafil API must detail both qualitative and quantitative parameters derived from validated testing protocols.
- RP-HPLC analysis provides quantitative separation of Tadalafil from potential synthetic degradation products, such as the hydantoin ring cleavage products or stereoisomeric impurities.
What is a Tadalafil API COA?
A Tadalafil API Certificate of Analysis (COA) is a lot-specific analytical document verifying the chemical identity, purity grade, and physical specifications of research-grade Tadalafil active pharmaceutical ingredient. It documents testing outcomes—including RP-HPLC purity percentages, mass spectrometry identification, residual solvent levels, heavy metal limits, and endotoxin content—ensuring raw materials meet rigorous laboratory research standards.
When sourcing active pharmaceutical ingredients for experimental assays, principal investigators rely on the COA to confirm structural integrity and rule out synthetic byproducts that could confound cellular or enzymatic assays. Each COA produced by an independent ISO 17025 accredited laboratory provides documented proof of quality, matching the specific lot identifier stamped on the compound container.
Molecular Profile and PDE5 Mechanism in Preclinical Models
Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor widely utilized in cardiovascular, vascular smooth muscle, and cellular signaling research. Chemically designated as (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, the molecule possesses a molecular formula of C22H19N3O4 and a molecular weight of 389.41 g/mol.
In preclinical models, Tadalafil competitive inhibition of the PDE5 enzyme prevents the degradation of cyclic guanosine monophosphate (cGMP) in vascular smooth muscle cells. Elevated intracellular cGMP concentrations promote protein kinase G (PKG) activation, leading to intracellular calcium sequestration and subsequent vascular relaxation. Investigators studying nitric oxide (NO) signaling cascades utilize research-grade Tadalafil to evaluate microvascular perfusion, endothelial responsiveness, and downstream gene expression without interference from uncharacterized chemical impurities.
Essential Quality Parameters Documented on a Valid COA
A compliant Certificate of Analysis for Tadalafil API must detail both qualitative and quantitative parameters derived from validated testing protocols. The primary metric is chemical purity, typically determined via Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC). For baseline laboratory research, a minimal purity threshold of 98.0%—and frequently >99.0%—is specified to limit trace isomers or synthesis reagents.
Beyond chromatographic purity, the COA must document molecular weight verification via Liquid Chromatography-Mass Spectrometry (LC-MS) or Nuclear Magnetic Resonance (NMR) spectroscopy. Secondary specifications include loss on drying (LOD), heavy metals analysis via Inductively Coupled Plasma Mass Spectrometry (ICP-MS), residual solvent quantification via Gas Chromatography (GC-Headspace), and elemental appearance (typically a white to off-white crystalline powder).
Analytical Methodologies: RP-HPLC and LC-MS Confirmation
RP-HPLC analysis provides quantitative separation of Tadalafil from potential synthetic degradation products, such as the hydantoin ring cleavage products or stereoisomeric impurities. Chromatograms included in or referenced by the COA display retention time (Rt) alignment against a known primary reference standard, along with peak area integration percentages that calculate total chemical purity.
Mass spectrometry confirms the molecular ion mass ([M+H]+ at m/z 390.14) to rule out structural misidentification. When auditing raw materials across a broader research peptide catalog, verifying that mass-to-charge ratios match theoretical values prevents systemic cross-contamination in high-throughput liquid handling systems.
Endotoxin Limits and Bioburden Verification
For cell culture assays, organ bath preparations, or animal tissue microperfusion studies, microbial contamination and bacterial endotoxins present severe experimental variables. Lipopolysaccharides (LPS) derived from Gram-negative bacteria induce inflammatory cytokine expression in vascular endothelium, skewing cGMP and nitric oxide measurement.
A robust Tadalafil API COA reports bacterial endotoxin levels evaluated via the Limulus Amebocyte Lysate (LAL) assay, expressed in Endotoxin Units per milligram (EU/mg). Standard research-grade thresholds require endotoxin levels to remain below defined limits (e.g., <0.1 EU/mg or <0.05 EU/mg depending on assay sensitivity). Laboratories establishing wholesale research accounts should verify that every batch undergoes stringent bioburden testing prior to experimental deployment.
Physicochemical Properties, Handling, and Reconstitution
Tadalafil API presents as a solid, hydrophobic crystalline powder that is practically insoluble in water (<0.01 mg/mL at 25°C). It exhibits low solubility in simple aqueous buffers but dissolves readily in organic solvents suitable for laboratory stock preparation, including dimethyl sulfoxide (DMSO) at concentrations up to 20–30 mg/mL, and dimethylformamide (DMF).
When preparing stock solutions for in vitro organ bath or enzyme kinetic assays, researchers typically dissolve the API in anhydrous DMSO before performing serial dilutions into physiological saline or cell culture media (maintaining final DMSO concentrations <0.1% v/v to avoid cellular toxicity). Store dry API powder in a desiccated environment at 2°C to 8°C or -20°C for long-term stability, avoiding repeated freeze-thaw cycles of liquid stock aliquots.
Comparative Preclinical Vascular Compounds
Investigators exploring vascular tone, sexual dimorphism in endothelial signaling, or microvascular perfusion frequently compare Tadalafil against alternative PDE5 inhibitors or non-enzymatic signaling agents. The distinct pharmacokinetic and binding affinity profile of Tadalafil (half-life in rodent models extending significantly longer than sildenafil or vardenafil) allows for prolonged cGMP elevation in chronic preclinical study designs.
In complex multi-pathway experiments, researchers often run parallel control groups evaluating distinct physiological targets. For instance, while PDE5 inhibitors modulate the cGMP pathway downstream, melanocortin receptor agonists such as PT-141 operate via central neurogenic signaling routes. Similarly, tissue repair and angiogenesis researchers may co-evaluate microvascular compounds alongside cytoprotective peptides like BPC-157. Comparing these distinct mechanisms requires baseline analytical consistency, emphasizing the need for verified COAs across all nitric oxide pathway studies.
Evaluating Sourcing Integrity and Lot Traceability
To safeguard research validity, research organizations must institute strict vendor verification protocols. A trustworthy supplier must furnish lot-specific documentation linked directly to physical batch numbers. Generic, redacted, or non-lot-specific COAs do not meet standard laboratory quality controls.
PX1 Research enforces comprehensive analytical oversight for all research compounds. Every lot of Tadalafil API undergoes independent third-party analytical validation in ISO 17025 accredited facilities within the United States. Batches are stored in climate-controlled warehouses in California and Arizona, utilizing GMP-compliant processing parameters to prevent moisture absorption or oxidative degradation prior to same-day dispatch.
Frequently Asked Questions
What information must appear on a Tadalafil API COA?
A compliant Tadalafil API COA must feature the lot/batch number, manufacturing date, retest date, RP-HPLC purity percentage, mass spectrometry identity confirmation, physical appearance, residual solvent levels, heavy metal limits, and bacterial endotoxin (LAL) test results.
Why is RP-HPLC purity critical for Tadalafil API in laboratory assays?
High chromatographic purity (>98.0% or >99.0%) ensures that unintended chemical intermediates, enantiomeric impurities, or synthesis byproducts do not interfere with PDE5 enzymatic binding kinetics or cause uncharacterized cytotoxic effects in cell culture.
How should Tadalafil API be reconstituted for in vitro research?
Tadalafil is hydrophobic and virtually insoluble in water. Researchers typically dissolve the API in dimethyl sulfoxide (DMSO) or DMF to create a concentrated stock solution, which is then diluted into aqueous culture media or buffer solutions immediately prior to testing.
What is the typical shelf life and storage requirement for Tadalafil API powder?
When stored in a desiccating container protected from light and moisture at 2°C to 8°C (or -20°C for extended periods), dry Tadalafil API powder typically maintains chemical stability for 24 to 36 months, as verified by periodic retest dates on the COA.
What endotoxin threshold is acceptable for cell-based research?
For sensitive cell culture and tissue preparations, bacterial endotoxin levels should ideally measure below 0.1 EU/mg (or <0.05 EU/mg for ultra-pure research grades) to ensure that bacterial lipopolysaccharides do not trigger non-specific inflammatory pathways.
Is Tadalafil API supplied by PX1 Research intended for human administration?
No. All products supplied by PX1 Research, including Tadalafil API, are manufactured strictly for in vitro laboratory research, analytical testing, and preclinical animal investigation. They are never for human or veterinary use.
How does Tadalafil compare to Sildenafil in preclinical binding studies?
Preclinical binding assays indicate Tadalafil exhibits higher selectivity for PDE5 over PDE6 (found in retinal tissue) compared to sildenafil, alongside a significantly longer terminal elimination half-life in animal tissue models.
Where are PX1 Research compounds synthesized and tested?
PX1 Research compounds are manufactured under strict laboratory standards, with every lot independently verified via third-party ISO 17025 accredited testing facilities in the USA prior to dispatch from facilities in California and Arizona.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.